Adenovirus and Fungal Load in Pediatric Stem Cell Transplant Patients
NCT00448994 · Status: WITHDRAWN · Type: OBSERVATIONAL
Last updated 2014-12-09
Summary
This study is designed to determine the rate at which stem cell transplant patients can develop infection caused by a group of viruses, known as adenovirus, and common fungi. Stem cells are unspecialized cells, capable of producing more stem cells or other specialized cells, and are used to replace damaged or diseased cells. The study will be conducted in children (2-17years old) being transplanted with stem cells from a donor. Patients undergoing stem cell transplantation are more likely to develop infections as their immune systems are weakened. Blood, stool, urine and throat swab samples will be collected (for at least 100 days on a weekly basis) to detect infection(s) caused by adenovirus or fungus. Subjects will participate for up to 1 year following the transplant procedure.
Conditions
- Adenovirus
- Other Mycoses
Sponsors & Collaborators
-
Steven B. Kleiboeker
lead INDUSTRY -
National Institute of Allergy and Infectious Diseases (NIAID)
collaborator NIH
Eligibility
- Min Age
- 2 Years
- Max Age
- 17 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2007-03-31
- Primary Completion
- 2011-07-31
- Completion
- 2011-07-31
Countries
- United States
Study Locations
More Related Trials
-
TMC125-TiDP2-C187: A Phase I, Open-label Trial to Investigate the Pharmacokinetic Interaction Between TMC125 and Two Antifungal Agents (Fluconazole and Voriconazole), All at Steady-state in Healthy Subjects.
NCT00740389 ·Status: COMPLETED ·Phase: PHASE1
-
MT2013-37R: Voriconazole Monitoring in Pediatric Stem Cell Transplant Patients
NCT02227797 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerance and Pharmacokinetics of Anidulafungin in Immunocompromised Children Ages 2-17
NCT00056381 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Comparison of Uncomplicated Candidemia Therapy Duration in Children
NCT05763251 ·Status: RECRUITING ·Phase: NA
-
Micafungin Prevention Study for Invasive Fungal Disease in Pediatric & Adolescent Patients Undergoing Autologous Hematopoietic Stem Cell Transplantation
NCT01417169 ·Status: UNKNOWN ·Phase: PHASE2
-
Voriconazole in Preventing Fungal Infections in Children With Neutropenia After Chemotherapy
NCT00066599 ·Status: COMPLETED ·Phase: PHASE2
-
A Multiple-Dose Study To Evaluate The Pharmacokinetics And Safety Of Voriconazole In Immunocompromised Adolescents
NCT00556998 ·Status: COMPLETED ·Phase: PHASE2
-
Micafungin Prevention Study for Fungal Disease in Child Receiving Allogenic Hematopoietic Stem Cell Transplantation
NCT01135589 ·Status: UNKNOWN ·Phase: PHASE4
-
Phase I Study of the Safety, Tolerance, and Pharmacokinetics of FK463 in Immunocompromised Children With Fever and Neutropenia
NCT00001790 ·Status: COMPLETED ·Phase: PHASE1
-
Anidulafungin Versus Fluconazole for the Prevention of Fungal Infections in Liver Transplant Recipients
NCT00841971 ·Status: COMPLETED ·Phase: PHASE4
-
Comparing the Effectiveness of Fluconazole and a New Medicine (FK463) in Preventing Fungal Infections in Bone Marrow Transplant Patients
NCT00001937 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of the Safety, Tolerance, and Pharmacokinetics of Oral Posaconazole in Immunocompromised Children (P03579)
NCT01716234 ·Status: TERMINATED ·Phase: PHASE1
-
An Open Label, Non-Comparative, Multicenter, Phase III Trial of the Efficacy, Safety and Toleration of Voriconazole in the Primary or Secondary Treatment of Invasive Fungal Infections
NCT00001757 ·Status: COMPLETED ·Phase: PHASE3
-
Fungal Prophylaxis With Isavuconazole for Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant (HCT)
NCT03149055 ·Status: COMPLETED ·Phase: PHASE2
-
A Pharmacokinetic Study of Pediatric Micafungin Prophylaxis
NCT02057289 ·Status: TERMINATED ·Phase: PHASE1
-
Oral Posaconazole Three Times Per Day vs Weekly High Dose Amphotericin B Lipid Complex (ABLC)
NCT00750737 ·Status: COMPLETED ·Phase: PHASE3
-
Comparison of Fluconazole vs Voriconazole to Treat Fungal Infections for Blood and Marrow Transplants (BMT CTN 0101)
NCT00075803 ·Status: COMPLETED ·Phase: PHASE3
-
Ravuconazole in Preventing Fungal Infections in Patients Undergoing Allogeneic Stem Cell Transplantation
NCT00064311 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Amphotericin B Cholesteryl Sulfate Complex for Injection(ABCD) in the Treatment of Invasive Candidiasis and Invasive Aspergillosis
NCT04225195 ·Status: UNKNOWN ·Phase: PHASE2
-
Voriconazole to Prevent Systemic Fungal Infections in Children
NCT00005912 ·Status: COMPLETED ·Phase: PHASE1
-
Voriconazole vs. Amphotericin B in the Treatment of Invasive Aspergillosis
NCT00001646 ·Status: COMPLETED ·Phase: PHASE3
-
Optimized Diagnostics for Improved Therapy Stratification in Invasive Fungal Infections
NCT02492594 ·Status: COMPLETED
-
BIOPIC: Fungal Biomarkers for Diagnosis and Response to Therapy for Pediatric Candidemia
NCT02220790 ·Status: COMPLETED
-
Amphotericin Alone or in Combination With Fluconazole for AIDS-Associated Meningitis
NCT00145249 ·Status: COMPLETED ·Phase: PHASE2
-
Voriconazole Versus Itraconazole In Primary Prophylaxis Of Invasive Fungal Infection (IFI) In Subjects With Allogeneic Hematopoietic Stem Cell Transplants (HSCT)
NCT00289991 ·Status: COMPLETED ·Phase: PHASE3